NRF2 is required for neonatal mouse beta cell growth by maintaining redox balance and promoting mitochondrial biogenesis and function

Sharon Baumel-Alterzon,Liora S. Katz,Luca Lambertini,Isabelle Tse,Fatema Heidery,Adolfo Garcia-Ocaña,Donald K. Scott
DOI: https://doi.org/10.1007/s00125-023-06071-7
IF: 8.2
2024-01-12
Diabetologia
Abstract:All forms of diabetes result from insufficient functional beta cell mass. Due to the relatively limited expression of several antioxidant enzymes, beta cells are highly vulnerable to pathological levels of reactive oxygen species (ROS), which can lead to the reduction of functional beta cell mass. During early postnatal ages, both human and rodent beta cells go through a burst of proliferation that quickly declines with age. The exact mechanisms that account for neonatal beta cell proliferation are understudied but mitochondrial release of moderated ROS levels has been suggested as one of the main drivers. We previously showed that, apart from its conventional role in protecting beta cells from oxidative stress, the nuclear factor erythroid 2-related factor 2 (NRF2) is also essential for beta cell proliferation. We therefore hypothesised that NRF2, which is activated by ROS, plays an essential role in beta cell proliferation at early postnatal ages.
endocrinology & metabolism
What problem does this paper attempt to address?